Pennsylvania Department of Health
PINE VIEW HEALTHCARE AND REHABILITATION CENTER
Patient Care Inspection Results

Note: If you need to change the font size, click the "View" menu at the top of the page, place the mouse over the "Text Size" menu item, and select the desired font size.

Severity Designations

Click here for definitions Click here for definitions Click here for definitions Click here for definitions
Minimal Citation - No Harm Minimal Harm Actual Harm Serious Harm
PINE VIEW HEALTHCARE AND REHABILITATION CENTER
Inspection Results For:

There are  194 surveys for this facility. Please select a date to view the survey results.

Surveys don't appear on this website until at least 41 days have elapsed since the exit date of the survey.
PINE VIEW HEALTHCARE AND REHABILITATION CENTER - Inspection Results Scope of Citation
Number of Residents Affected
By Deficient Practice
Initial comments:

Based on a Medicare/Medicaid Recertification survey, State Licensure survey, Civil Rights Compliance, and an Abbreviated Complaint survey completed on July 23, 2026, it was determined that Pine View Healthcare and Rehabilitation Center was not in compliance with the following requirements of 42 CFR Part 483, Subpart B, Requirements for Long Term Care Facilities and the 28 PA Code, Commonwealth of Pennsylvania Long Term Care Licensure Regulations.




 Plan of Correction:


483.25 REQUIREMENT Quality of Care:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§ 483.25 Quality of care
Quality of care is a fundamental principle that applies to all treatment and care provided to facility residents. Based on the comprehensive assessment of a resident, the facility must ensure that residents receive treatment and care in accordance with professional standards of practice, the comprehensive person-centered care plan, and the residents' choices.
Observations:

Based on interview with staff, observation, and review of clinical records, the facility failed to implement a recommendation from the Registered Dietitian that was signed by the Primary Care Provider in a timely fashion and failed to follow a physician's order for two of 16 residents reviewed (Resident 80, 165).

Findings include:

Review of Resident 80's admission MDS (Minimum Data Set - a mandatory assessment of a resident's physical condition and care needs), dated May 22, 2026, revealed that Resident 91 was admitted to the facility on May 15, 2026 from the hospital with diagnoses that included anemia (abnormally low red blood cell count) and malnutrition (when the body does not receive the nutrients it needs to function).

Review of hospital consultation records dated May 11, 2026 revealed "Severe malnutrition with BMI (body mas index - a measure of health using weight to height ratios) 12.85."
Review of Resident 80's weights revealed the following:

May 15, 2026: 77.4 pounds
May 16, 2026: 77.6 pounds
May 20, 2026: 73 pounds
May 27, 2026: 79.8 pounds
June 3, 2026: 79.2 pounds
June 10, 2026: 79.0 pounds
June 17, 2026: 75.6 pounds
July 7, 2026: 82.4 pounds

Review of the facility's dietary assessment dated May 22, 2026, revealed that Resident 80 met the criteria for severe protein-calorie malnutrition due to meeting two or more criteria: Unplanned weight loss of greater than 5% in one month, BMI less than 20 for a resident more than 70 years old, and muscle mass loss. Interventions included a nutrition supplement, Ensure (a nutritional drink and protein supplement) daily. This assessment was signed by the Registered Dietitian and the Primary Care Provider on May 22, 2026.

Interview with the Registered Dietitian (E6) on July 23, 2026, at approximately 11:50 a.m. revealed that a dietary recommendation signed by the provider should be implemented within a day.

Review of Resident 80's medication administration record revealed that the order for Ensure was not added to the resident's orders until June 20, 2026, placing the resident at risk for additional weight loss and malnutrition.

This finding was shared with the Director of Nursing and Nursing Home Administrator on July 23, 2026 at approximately 2:15 p.m.

A review of Resident 165's wound consults note dated June 10, 2026, revealed "Wound care has been consulted for evaluation and treatment recommendation regarding Stage 4 (Full-thickness skin and tissue loss) pressure ulcer to right hip, with history of osteomyelitis (bone infection) and hardware exposure. Patients have pain that increases with pressure and dressing changes, relieved with offloading, rest, and pain meds. Patient is declining any further surgical intervention at this time; currently taking Doxycycline (antibiotic) 100mg BID prophylactic per ID (Infectious Disease) recommendations. The same report revealed as follows: "ASSESSMENT/PLAN: Right Hip-Stage 4-no healing expected/poor prognosis per surgeon (patient needs surgery but not a candidate)- goals of care to prevent infection and reduce pain-due to maceration of peri wound and increase in wound size".

A review of Resident 165's primary physician's notes dated June 12, 2026, at 5:23 p.m., revealed "R (right) Hip Pain-continue Tylenol--follow up with Ortho (Orthopedics- a medical doctor that specializes in diagnosing, and treating bone disease) [Physician's name].

There was no documentation indicating that the physician's order for a follow-up with the Orthopedic doctor was followed from June 12, 2026, until July 22, 2026.

On July 23, 2026, at 11:45 a.m., the Director of Nursing (DON) handed the surveyor an "Appointment Slip" paper with information indicating that Resident 165's Orthopedic consult is scheduled for July 24, 2026, at 10:50 a.m., after the surveyor had asked regarding the consult. When asked when the schedule was made, the DON replied, "I don't know, I'll ask the scheduler". At 1:00 p.m., a follow-up was done with the DON to determine when the consult schedule was made; no answer was provided. At 2:10 p.m., a follow-up was made with the DON. The surveyor asked again if they were able to talk to the scheduler; the DON replied "No". When asked why, they replied, "I called but [they] are not answering". When asked if the scheduler was in the building, the DON replied, "I don't know". The surveyor asked if they could find out. The DON did not come back to provide an answer.

The above was conveyed with the Nursing Home Administrator on July 23, 2026, at 2:45 p.m.

The facility failed to ensure Resident 165's physician's order for a follow-up with an Orthopedic doctor was followed.

28 Pa. Code 211.5(f) Clinical Records

28 Pa. Code 211.12(d)(1)(5) Nursing Services






 Plan of Correction - To be completed: 09/09/2026

Resident R80 has order for ensure in place and no adverse effects occured.
Resident R165 had the ortho consult completed.
All residents on 2 West were audited for the previous four weeks to ensure that any outstanding Registered Dietitian (RD) recommendations related to Ensure supplementation were appropriately addressed and followed up on.
Additionally, all residents on 2 West were audited to ensure that any outstanding orthopedic consult recommendations were identified and appropriate follow-up was completed.
The DON/Designee provided education to Licensed nursing staff regarding the importance of timely follow-up and completion of physician and interdisciplinary recommendations, including RD recommendations for Ensure and orthopedic appointments.
The DON/Designee will complete weekly audits of five residents per unit weekly x4, followed by monthly x2 audits thereafter, to ensure compliance with physician and interdisciplinary recommendations. Audit results will be reviewed through QAPI, with additional interventions or recommendations implemented as needed.

483.25(k) REQUIREMENT Pain Management:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.25(k) Pain Management.
The facility must ensure that pain management is provided to residents who require such services, consistent with professional standards of practice, the comprehensive person-centered care plan, and the residents' goals and preferences.
Observations:

Based on interview, observation, and clinical record review, the facility failed to administer pain medication in accordance with physician's orders for 1 out of 8 residents reviewed (Resident 91).

Findings include:

Review of Resident 91's quarterly MDS (minimum data set a mandatory assessment of a resident's physical condition and care needs) dated April 9, 2026, revealed that Resident 91 received scheduled pain medication for "frequent" pain that "frequently" interfered with sleep and participation in rehabilitation therapy sessions, and "frequently" caused them to limit their day-to-day activities. The RAI (Resident Assessment Instrument - a tool that helps facility staff gather information on a resident's strengths and needs for the MDS) defines "frequent" as pain that is present and interferes with activities such as sleep, participation in rehabilitation therapy or day-to-day activities over the last five days of the resident's MDS assessment period. The pain was recorded as "severe" in the MDS.

Review of provider History and Physical dated February 18, 2025, revealed Resident 91's diagnoses included: alcoholic polyneuropathy (a progressive nerve disorder that leads to pain and weakness in the arms and legs) and multilevel degenerative disc disease (age-related wear and tear affecting several areas of the spine that causes pain and stiffness).

Review of the July 2026 MAR (medication administration record) revealed Resident 91 had orders for Amitriptyline HCl at bedtime for neuropathic (nerve) pain, Celebrex for pain management, Valium for muscle spasms, Tylenol Extra Strength for pain, Gabapentin for neuropathy pain, and oxycodone HCl 10 mg every 6 hours (12:00 a.m., 6:00 a.m., 12:00 p.m., and 6:00 p.m.) for pain management.

Review of nursing progress notes dated June 8, 2026, at 11:00 p.m. revealed that Resident 91's oxycodone HCL order was increased from 5mg to 10mg every 6 hours for pain management.

Review of Resident 91's MAR revealed that Resident 91 did not receive scheduled oxycodone on the following days:

July 11, 2026: 12:00 p.m.
Jul7 11, 2026: 6:00 p.m.
July 12, 2026: 12:00 a.m.
July 12, 2026: 6:00 a.m.
July 12, 2026: 12:00 p.m.
July 12, 2026: 6:00 p.m.
July 13, 2026:12:00 a.m.

Review of Resident 91's July 2026 TAR (treatment administration record) revealed that Resident 91's pain was to be assessed each shift utilizing a numeric pain scale (a tool to measure pain levels from zero to ten with zero indicating no pain and ten being the most severe pain). Resident 91's pain was assessed as follows:

July 11, 2026, 7 a.m. to 3:00 p.m. pain level = 0/10
July 11, 2026, 3:00 p.m. to 11:00 p.m. pain level = 0/10
July 11, 2026, 11:00 p.m. to 7:00 a.m. pain level = 0/10
July 12, 2026, 7 a.m. to 3:00 p.m. pain level = 8/10
July 12, 2026, 3:00 p.m. to 11:00 p.m. pain level = 0/10
July 12, 2026, 11:00 p.m. to 7:00 a.m. pain level = 8/10
July 13, 2026, 7:00 a.m. to 3:00 p.m. pain level = 8/10

Review of nursing progress note dated July 11, 2026, at 6:00 p.m. for oxycodone HCL 10mg, revealed: "Awaiting pharmacy delivery."

Review of nursing progress note dated July 12, 2026, at 1:11 a.m., for oxycodone HCL 10mg, revealed: No medication in the building, supervisor aware, MD (physician) and RP (responsible party) aware."

Review of nursing progress note dated July 12, 2026, at 3:58 a.m. revealed: "resident was notified that there were no more oxycodone, resident was very upset and asked how we can get it, informed resident that we needed order from MD to get a new script."

Review of nursing progress note dated July 12, 2026, at 7:01 a.m. for oxycodone HCL 10mg, revealed: "Medication still not received. MD and RP made aware."

Review of nursing progress note dated July 12, 2026, at 2:54 p.m. for oxycodone HCL 10mg revealed, "Med not available. MD made aware. Resident is [there] own RP."

Review of nursing progress note dated Jul 13, 2026, at 2:19 p.m. revealed: "Resident's oxycodone is expected to arrive on the first pharmacy delivery run today ...at this time, resident appears comfortable."

Review of the facility's list of on-site medication provided by the pharmacy, on July 23, 2026, revealed that Resident 91's oxycodone was not kept in inventory.

Interview with the Director of Nursing on July 23, 2026 at approximately 12:30 p.m., revealed that because the pharmacy's servers were experiencing downtime, it wasn't possible to determine if the delay in receiving Resident 91's medication was related to the provider not requesting a refill in a timely manner or the facility not requesting the refill.

The facility failed to provide Resident 91 with scheduled pain medication resulting in physical discomfort for the resident over multiple shifts.

This finding was shared with the Director of Nursing and the Nursing Home Administrator on July 23, 2026 at approximately 2:30 p.m.

28 Pa. Code 211.12(d)(5) Nursing Services





 Plan of Correction - To be completed: 09/09/2026

Resident 91s MEDICATION WAS REVIEWED AND IS AVAIBLE PER ORDER

The Facility generated a facility-wide list of every resident with a scheduled controlled-substance order and checked each against current on-hand inventory. No other residents were identified to not have their medication on hand.
DON / Designee educated nurses on timely reordering of narcotics to ensure proper pain management
DON/Designee will audit 5 residents per unit weekly ×4 and monthly ×2 to ensure they have their ordered narcotics medications on hand. Results will be brought to QAPI for review and recommendations as needed.

483.45(c)(1)(2)(4)(5) REQUIREMENT Drug Regimen Review, Report Irregular, Act On:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.45(c) Drug Regimen Review.
§483.45(c)(1) The drug regimen of each resident must be reviewed at least once a month by a licensed pharmacist.

§483.45(c)(2) This review must include a review of the resident's medical chart.

§483.45(c)(4) The pharmacist must report any irregularities to the attending physician and the facility's medical director and director of nursing, and these reports must be acted upon.
(i) Irregularities include, but are not limited to, any drug that meets the criteria set forth in paragraph (d) of this section for an unnecessary drug.
(ii) Any irregularities noted by the pharmacist during this review must be documented on a separate, written report that is sent to the attending physician and the facility's medical director and director of nursing and lists, at a minimum, the resident's name, the relevant drug, and the irregularity the pharmacist identified.
(iii) The attending physician must document in the resident's medical record that the identified irregularity has been reviewed and what, if any, action has been taken to address it. If there is to be no change in the medication, the attending physician should document his or her rationale in the resident's medical record.

§483.45(c)(5) The facility must develop and maintain policies and procedures for the monthly drug regimen review that include, but are not limited to, time frames for the different steps in the process and steps the pharmacist must take when he or she identifies an irregularity that requires urgent action to protect the resident.
Observations:

Based on a review of pharmacy consultants' monthly medication review (MMR), clinical records review, and staff interview, it was determined that the facility failed to act on the pharmacist's recommendations for one of five residents reviewed (Resident 59).

Findings:

A review of Resident 59's physician's order dated January 5, 2025, revealed an order for Sertraline HCL (antidepressant medication), one tablet daily, related to Major Depressive Disorder (Characterized by a low mood or loss of interest in activities that last for a long time that can interfere with normal functioning).

A review of Resident 59's physician order dated April 2, 2025, revealed an order for Remeron tablet (antidepressant medication) 30 mg, one tablet by mouth at bedtime for depression.

A review of Resident 59's April 16, 2026, Pharmacy consultant review revealed: "As per CMS (Centers for Medicare &; Medicaid Services) guidelines, a taper of Sertraline and Remeron may be indicated. If a taper of this medication is contraindicated, please document the clinical rationale". The response was "Accepted" with a check mark on the physician's signature line.

A review of Resident 59's physician's order from May 2026 until July 2026 revealed that there were no changes made to the resident's Sertraline and Remeron order.

An interview was conducted with the Director of Nursing (DON) on July 24, 2026, at 1:00 p.m. The DON confirmed that the pharmacy recommendations made on April 16, 2026, to taper the Sertraline and Remeron were not addressed/followed.

The facility failed to ensure Resident 59's Pharmacy consultants' recommendations made on April 16, 2026, to taper the resident's antidepressant medications were addressed/followed.

28 Pa. Code 211.5(f) Clinical Records

28 Pa. Code 211.12(d)(1)(5) Nursing Services






 Plan of Correction - To be completed: 09/09/2026

Facility reviewed pharmacist monthly medication review report for all current residents facility-wide for the preceding 3 months, and confirmed each irregularity/recommendation had either a documented physician response and order change, or a documented clinical rationale for no change. No additional residents with an unaddressed recommendation were identified.
DON / Designee educated All unit managers educated on pharmacy recommendations and proper follow up.
DON/Designee will audit 5 residents weekly ×4 and monthly ×2 to ensure their pharm recs are being followed up on properly. Results will be brought to QAPI for review and recommendations as needed.

483.45(d)(1)-(6) REQUIREMENT Drug Regimen is Free from Unnecessary Drugs:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.45(d) Unnecessary Drugs-General.
Each resident's drug regimen must be free from unnecessary drugs. An unnecessary drug is any drug when used-

§483.45(d)(1) In excessive dose (including duplicate drug therapy); or

§483.45(d)(2) For excessive duration; or

§483.45(d)(3) Without adequate monitoring; or

§483.45(d)(4) Without adequate indications for its use; or

§483.45(d)(5) In the presence of adverse consequences which indicate the dose should be reduced or discontinued; or

§483.45(d)(6) Any combinations of the reasons stated in paragraphs (d)(1) through (5) of this section.
Observations:

Based on a review of the facility's policy, clinical records review, observations, and staff interview, it was determined that the facility administered an as-needed anti-anxiety medication without appropriate indications and non-drug interventions and failed to monitor and report psychotropic side effects for two of five residents reviewed (Resident 8 and 225).

Findings:

A review of the facility's policy titled "Psychotropic Medication Use", undated, revealed the following: Residents will not receive medications that are not clinically indicated to treat specific conditions; Non-pharmacological approaches are used to minimize the need for medications, permit the lowest possible dose, and allow for discontinuation of medication when possible; Residents receiving psychotropic medications are monitored for adverse consequences, including anticholinergic effects-flushing, blurred vision, dry mouth, altered mental status, difficulty urinating etc.; neurologic effects-agitation, distress, and extrapyramidal symptoms (EPS-are drug induced movement disorders).

A review of Resident 8's "Psychiatric Evaluation &; Consultation" dated November 5, 2025, revealed the resident had the following diagnoses: Bipolar Disorder (A Disorder associated with episodes of mood swings ranging from depressive lows to manic highs) and schizoaffective disorder (A chronic mental health condition that combines symptoms of Schizophrenia with a mood disorder). The same report revealed residents observed hand tremors with recommendations to continue monitoring tremors and reporting any changes or additional symptoms. Further review revealed an AIMS (A test used to assess and monitor involuntary movements) was completed on November 6, 2025. The same report revealed the resident was on the following psychotropic medications: Depakote (A medication used to treat seizure disorder, manic episodes with bipolar disorder), 125 mg twice daily; Sertraline, 125 mg daily (Anti-depression medications); Risperdal, 2.5 mg twice daily (anti-psychotic medications); and Benztropine (A medication used to treat extrapyramidal disorders caused by antipsychotic drugs).

A review of the Resident 8 June 2026 Medications Administration Record (MAR) revealed the residents' behaviors and side effects were monitored until June 15, 2026.

A review of the nursing readmission notes dated June 23, 2026, revealed the resident was readmitted to the facility post hospitalizations (June 15, 2026) for diagnosis of Hypernatremia (elevated sodium level).

A review of Resident 8's admission physician orders dated June 23, 2026, revealed the following orders: Seroquel 5 mg (Anti-psychotic medication) at nighttime, Sertraline 125 mg daily, and Depakote 125 mg twice daily.

An observation conducted on July 20, 2026, at 1:27 p.m., revealed the resident was lying on the bed. Attempted to interview the resident, but they were confused and disoriented; however, while talking, the resident was observed with lip smacking and tongue thrusting.

An observation was conducted on July 21, 2026, at 10:45 a.m. in the presence of a Speech Therapist, Employee E4. Observation revealed the resident was lying in bed and, while talking, observed lip smacking and tongue thrusting.

An interview was conducted with Employee E4 on July 20, 2026, at 10:45 a.m. Employee E4 reported observing the residents with tongue thrusting when evaluated on July 24, 2026. Employee E4 reported that it was the resident's "baseline".

An observation was conducted on July 21, 2026, at 12:30 p.m., in the presence of licensed nurse Employee E6. Observation revealed the resident was lying in bed and, while talking, observed lip smacking and tongue thrusting.

An interview was conducted with Employee E6 on July 21, 2026, at 12:30 p.m. Employee E6 reported that they were the residents' morning full-time nurse. Employee E6 reported noticing the residents with lip smacking since last Saturday (July 18, 2026). Employee E6 reported that the resident was monitored for "dry mouth".

There was no documented evidence that Resident 8 was monitored for medication side effects since the Seroquel was started on June 23, 2026. Further review also revealed that there were no documentation that the physician was notified of the possible medications side effects observed by Employee E4 and Employee E6.

The psychotropic side effects monitoring was ordered on July 22, 2026, at 1:03 p.m., and started at 3:00 p.m.

A review of Resident 225's physician's order dated June 26, 2026, revealed an order for Lorazepam (An anti-anxiety medication) 0.5 mg every eight hours as needed for anxiety.

A review of Resident 225's July 2026 Medication Administration Record (MAR) revealed that from July 1, 2026, until July 22, 2026, the resident was administered as-needed Lorazepam nine times.

A review of Resident 225's nursing progress notes from July 1, 2026, until July 22, 2026, revealed the resident was administered as-needed Lorazepam six times without appropriate indications and five times without providing non-pharmacological interventions.

The above was conveyed to the Director of Nursing on July 23, 2026, at 1:00 p.m.

The facility failed to ensure Resident 8 was monitored for psychotropic medication side effects and Resident 225 was administered as-needed anti-anxiety medication without appropriate indications and non-pharmacological interventions.

28 Pa. Code 211.12(d)(1)(3)(5) Nursing services

28 Pa Code 211.5(f) Clinical Records

28 PA Code 211.10(a) Resident care policies






 Plan of Correction - To be completed: 09/09/2026

Residents that were identified now have proper order for NPI and side effect monitoring
All residents who are prescribed PRN psychotropic medications were audited to ensure appropriate side effects and behavior monitoring as well as NPI's was implemented and documented.
The DON/Designee provided education to all licensed nurses regarding the importance of accurately documenting specific behaviors, side effects and non pharm interventions .(
The DON/Designee will weekly audit 5 residents a week x4 and monthly audits x2 to ensure proper side effect monitoring and accurate behavioral documentation and NPI are completed for residents receiving PRN psychotropic medications. Audit results will be reviewed through QAPI, with additional interventions or recommendations implemented as needed.

483.45(g)(h)(1)(2) REQUIREMENT Label/Store Drugs and Biologicals:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.45(g) Labeling of Drugs and Biologicals
Drugs and biologicals used in the facility must be labeled in accordance with currently accepted professional principles, and include the appropriate accessory and cautionary instructions, and the expiration date when applicable.

§483.45(h) Storage of Drugs and Biologicals

§483.45(h)(1) In accordance with State and Federal laws, the facility must store all drugs and biologicals in locked compartments under proper temperature controls, and permit only authorized personnel to have access to the keys.

§483.45(h)(2) The facility must provide separately locked, permanently affixed compartments for storage of controlled drugs listed in Schedule II of the Comprehensive Drug Abuse Prevention and Control Act of 1976 and other drugs subject to abuse, except when the facility uses single unit package drug distribution systems in which the quantity stored is minimal and a missing dose can be readily detected.
Observations:

Based on observations and staff interviews, it was determined that the facility failed to ensure medications were properly stored and labeled for one of the five medication carts observed (2 West back medication cart).

Findings:

An observation of the 2 West back medication cart was conducted on July 21, 2026, at 10:00 a.m., in the presence of licensed nurse Employee E3. The observation revealed the following: 27 scattered pills of different colors and shapes in the second drawer; 9 scattered pills of different colors and shapes in the third drawer; a medicine cup containing 7 tablets; and a medicine cup containing crushed medication.

An interview was conducted with Employee E3 on July 21, 2026, at 10:03 a.m. Employee E3 reported that the two-medication cup containing unlabeled medications belongs to two different residents who were not yet ready to take their medications.

The above was conveyed to the Director of Nursing on July 23, 2026, at 10:00 1:00 p.m.
The facility failed to ensure medications on the 2 West back medication cart were properly stored and labeled.

28 Pa. Code 211.12(d)(1)(5) Nursing Services









 Plan of Correction - To be completed: 09/09/2026

The 2 West back medication cart was immediately cleaned out; all loose, unlabeled pills and medication cups were removed, identified where possible, and discarded per facility waste policy, and the cart was restocked with properly labeled medications only.
The DON / designee did an inspection of every medication cart on all 5 units to confirm no other loose, unlabeled, or improperly stored medications were present. No additional issues were found on any other cart.
Licensed nursing staff were re-educated by DON/ Designee on proper medication labeling and storage
DON/Designee will audit each med cart weekly ×4 and monthly ×2 to ensure medication storage protocol is being followed. Results will be brought to QAPI for review and recommendations as needed.

483.20(f)(5),483.70(h)(1)-(5) REQUIREMENT Resident Records - Identifiable Information:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.20(f)(5) Resident-identifiable information.
(i) A facility may not release information that is resident-identifiable to the public.
(ii) The facility may release information that is resident-identifiable to an agent only in accordance with a contract under which the agent agrees not to use or disclose the information except to the extent the facility itself is permitted to do so.

§483.70(h) Medical records.
§483.70(h)(1) In accordance with accepted professional standards and practices, the facility must maintain medical records on each resident that are-
(i) Complete;
(ii) Accurately documented;
(iii) Readily accessible; and
(iv) Systematically organized

§483.70(h)(2) The facility must keep confidential all information contained in the resident's records,
regardless of the form or storage method of the records, except when release is-
(i) To the individual, or their resident representative where permitted by applicable law;
(ii) Required by Law;
(iii) For treatment, payment, or health care operations, as permitted by and in compliance with 45 CFR 164.506;
(iv) For public health activities, reporting of abuse, neglect, or domestic violence, health oversight activities, judicial and administrative proceedings, law enforcement purposes, organ donation purposes, research purposes, or to coroners, medical examiners, funeral directors, and to avert a serious threat to health or safety as permitted by and in compliance with 45 CFR 164.512.

§483.70(h)(3) The facility must safeguard medical record information against loss, destruction, or unauthorized use.

§483.70(h)(4) Medical records must be retained for-
(i) The period of time required by State law; or
(ii) Five years from the date of discharge when there is no requirement in State law; or
(iii) For a minor, 3 years after a resident reaches legal age under State law.

§483.70(h)(5) The medical record must contain-
(i) Sufficient information to identify the resident;
(ii) A record of the resident's assessments;
(iii) The comprehensive plan of care and services provided;
(iv) The results of any preadmission screening and resident review evaluations and determinations conducted by the State;
(v) Physician's, nurse's, and other licensed professional's progress notes; and
(vi) Laboratory, radiology and other diagnostic services reports as required under §483.50.
Observations:

Based on interview with staff and clinical record review, it was determined that the facility failed to maintain complete and accurate medical records related to treatments and observations for two of five residents reviewed (Resident 15, and Resident 217).

Findings include:

Resident 15 has medical diagnoses that include Dysphagia (difficulty swallowing) following Cerebral Infarction (a condition that occurs when blood flow to a part of the brain is interrupted), Aphasia (impaired speaking and understanding), following Cerebral Infarction, Gastrostomy (a medical procedure that creates an opening from the abdominal wall into the stomach to provide nutrition), Hemiplegia (a neurological condition characterized by paralysis or severe weakness affecting one side of the body) and Hemiparesis (weakness or partial paralysis affecting one side of the body, often caused by brain, spinal cord, or nerve damage) following other Cerebrovascular Disease affecting right dominant side.

Review of Resident 15's care plan revealed a focus initiated on November 5, 2025, revised on July 17, 2026, documenting the resident has a nutritional problem or potential nutritional problem related to age, need for therapeutic/mechanically altered diet, need for enteral feed (a soft, flexible tube that delivers nutritionally complete liquid feeds, including protein, carbohydrates, fats, vitamins, minerals, and water, directly into the gastrointestinal tract to meet nutrition and hydration needs), risk for malnutrition, on hospice care, and historic need for oral nutritional supplements secondary to malnutrition risk.

Further review of Resident 15's care plan revealed a focus dated November 14, 2024, documenting the resident has Aphasia related to Cerebral Infarction.

Review of Resident 15's physician orders revealed an order dated July 17, 2026, for Enteral Feed every 4 hours (hr.) for Enteral Nutrition/Hydration flush Percutaneous Endoscopic Gastrostomy (PEG tube)(a small, flexible tube placed through the abdominal wall into the stomach to deliver nutrition, fluids, and medications) with 200 milliliters (ml) of water every 4 hours, total volume of flush to equal 1200 ml every 24 hrs. (excluding medication flushes). Total volume of nutrient plus flush to equal 1980 ml every 24 hrs.

Review of Resident 15's July 2026 Medication Administration Report (MAR) revealed total daily flush amounts as follows:

July 18, 2026, total volume of 2768 ml. for the day.
July 19, 2026, total volume of 1620 ml. for the day.
July 21, 2026, total volume of 1065 ml. for the day.

On July 17, 2026, at 1:00 p.m. the resident's MAR documents a flush volume of 400 ml.

Per Resident 15's July MAR, there were three days in July 2026, when the resident's total volume of flush every four hours exceeded the physician ordered amount. There was one day when the resident's total volume of flush was less than the physician ordered amount.

Interview conducted with the Director of Nursing (DON) on July 22, 2026, at 1:20 p.m., when the above was presented, the DON confirmed there were days when the resident did not receive the accurate daily total flush amounts. The DON stated the order was probably being misunderstood by the staff and the wording would be changed to avoid confusion.

Resident 217 has medical diagnoses that include Heart Failure, Cerebral Infarction, Cirrhosis of Liver (advanced scarring of the liver), and Major Depressive Disorder, Adjustment Disorder, Thigh Pain, and Muscle Weakness.

Review of Resident 217's care plan revealed a focus initiated on January 19, 2026, documenting the resident has a diagnosis of depression.

Review of Resident 217's care plan revealed a focus initiated on January 19, 2026, documenting the resident has potential for pain related to arthritis and neuropathy.

Review of Resident 217's physician orders revealed an order dated February 3, 2026, for Tramadol (medication for moderate to severe pain) HCl Oral Tablet 50 milligrams (mg) give 1 tablet by mouth every 12 hours as needed for severe pain.

Review of Resident 217's physician orders revealed an order dated January 23, 2026, for Sertraline (medication used to treat depression) HCl Oral Tablet 25 mg give 1 tablet by mouth one time a day for depression.

Review of Resident 217's physician orders revealed an order dated January 17, 2026, for Observation: Pain - Observe every shift. If pain is present complete pain flow sheet and treat trying non-pharmacologic interventions prior to medicating if appropriate. Document in the progress notes.

Review of Resident 217's July MAR revealed the following:

July 4, 2026, pain level of 7 during 2nd shift.
July 5, 2026, pain level of 5 during 2nd shift and 3rd shift.
July 17, 2026, pain level of 9, during 2nd shift.
July 21, 2026, pain level of 4, during 3rd shift.

Review of Resident 217's progress notes revealed no non-pharmacological interventions documented.

During interview conducted with the DON on July 22, 2026, at 1:20 p.m., the DON stated the facility does not utilize pain flow sheets, the MAR is considered their pain flow sheet.

Review of Resident 217's physician orders revealed an order dated January 17, 2026, for Observation: Antidepressant Medication - Observe for behavior of depression. Observe for side effects: GI upset, insomnia, fatigue, dizziness, dry mouth, headache. Document "Y" if resident is free of side effects. Document "N" if the resident is NOT free from side effects. If "N" document side effects in the progress notes every shift for protocol.

Review of Resident 217's July MAR revealed the following:

July 1, 2026, No was documented for the 2nd and 3rd shifts.
July 2, 2026, No was documented for all shifts.
July 3, 2026, No was documented for all shifts.
July 4, 2026, No was documented for 1st and 2nd shifts.
July 5, 2026, No was documented for 1st and 3rd shifts.
July 6, 2026, No was documented for all shifts.
July 7, 2026, No was documented for all shifts.
July 8, 2026, No was documented for all shifts.
July 9, 2026, No was documented for all 2nd and 3rd shifts.
July 10, 2026, No was documented for all shifts.
July 11, 2026, No was documented for 3rd shift.
July 12, 2026, No was documented for 2nd and 3rd shifts.
July 13, 2026, No was documented for all shifts.
July 14, 2026, No was documented for 1st and 3rd shifts.
July 15, 2026, No was documented for all shifts.
July 16, 2026, No was documented for all shifts.
July 17, 2026, No was documented for all shifts.
July 18, 2026, No was documented for 1st and 3rd shifts.
July 19, 2026, No was documented for all shifts.
July 20, 2026, No was documented for all shifts.
July 21, 2026, No was documented for 1st shift.
July 22, 2026, No was documented for 1st shift.

Review of Resident 217's progress notes revealed no side effects were documented for the antidepressant observations.

Interview conducted with the Director of Nursing (DON) on July 22, 2026, at 1:20 p.m., when the above was presented, the DON stated the order was probably being misunderstood by the staff and the wording would be changed to avoid confusion.

28 Pa. Code 211.5(f)(h) Clinical records.

28 Pa. code 211.12(d)(1)(3)(5) Nursing services.




















 Plan of Correction - To be completed: 09/09/2026

NPI was put in place for Tramadol order
Peg Flush orders were clarified for understanding
The DON/Designee completed an audit of all residents with G-tubes to ensure daily flush amounts were accurate and consistent with current orders. No additional issues or concerns were identified during the audit.
An audit was also completed by DON / Designee for all residents on antidepressant medications to ensure appropriate side effect monitoring was in place. Medication orders were reviewed and updated, as needed, to include required side effect monitoring and NPI documentation to ensure accurate and complete records are maintained.
Licensed nursing staff were re-educated on accurate documentation related to NPI's for and side effect monitoring for
The DON/Designee will complete weekly audits x4 and monthly x2 of five residents receiving antidepressant medications and five residents with PEG tube flushes to ensure accurate documentation.
Results will be brought to QAPI for review and recommendations as needed.


Back to County Map


  
Home : Press Releases : Administration
Health Planning and Assessment : Office of the Secretary
Health Promotion and Disease Prevention : Quality Assurance



Copyright © 2001 Commonwealth of Pennsylvania. All Rights Reserved.
Commonwealth of PA Privacy Statement

Visit the PA Power Port